Antinociceptive activity of the monoterpene α-phellandrene in rodents: Possible mechanisms of action

Journal of Pharmacy and Pharmacology

Volumn 64, Issue 2, 2012, Pages 283-292

  Lima, David F ^a   Brandã, Marcela S ^a   Moura, Joelma B ^a   Leitão, Joseana M R S ^a   Carvalho, Fernando A A ^a   Miúra, Leiz M C V ^a   Leite, José R S A ^a   Sousa, Damião P ^b   Almeida, Fernanda R C ^a  

^a FEDERAL UNIVERSITY OF PIAUÍ   (Brazil)

^b FEDERAL UNIVERSITY OF SERGIPE   (Brazil)

Author keywords

phellandrene; antinociceptive effect; monoterpene

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; ADENOSINE TRIPHOSPHATE SENSITIVE POTASSIUM CHANNEL; ALPHA PHELLANDRENE; ENDORPHIN; INDOMETACIN; NITRIC OXIDE;

ADRENERGIC SYSTEM; ANALGESIC ACTIVITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTINOCICEPTION; ARTICLE; CHOLINERGIC SYSTEM; CONTROLLED STUDY; CYTOTOXICITY TEST; DOSE RESPONSE; DRUG DOSE COMPARISON; DRUG EFFECT; DRUG MECHANISM; DRUG PURITY; DRUG SCREENING; DRUG STRUCTURE; ELECTROSPRAY MASS SPECTROMETRY; HYPERALGESIA; MALE; MOLECULAR WEIGHT; MOUSE; NOCICEPTIVE PAIN; NONHUMAN; PAW EDEMA; PERITONEUM MACROPHAGE; PSYCHOMOTOR PERFORMANCE; WRITHING TEST;

ANALGESICS; ANIMALS; MALE; MASS SPECTROMETRY; MICE; MONOTERPENES; MOTOR ACTIVITY; OILS, VOLATILE; PAIN; PAIN MEASUREMENT; RATS; RATS, WISTAR;

EID: 84855426626     PISSN: 00223573     EISSN: 20427158     Source Type: Journal    
DOI: 10.1111/j.2042-7158.2011.01401.x     Document Type: Article

References (54)

1. The International Association for Study of Pain. IASP pain terminology. 1994. Available at: (accessed June 2011).
2. Mc Grath PA,. Psychological aspects of pain perception. Arch Oral Biol 1994; 39 (Suppl. 39): 55S-62S.
3. Strahl C, et al,. The role of pain anxiety, coping, and pain self-efficacy in rheumatoid arthritis patient functioning. Behav Ver Ther 2000; 38: 863-873. (Pubitemid 30336421)
4. Bair MJ, et al,. Depression and pain comorbidity: a literature review. Arch Intern Med 2003; 163: 2433-2445. (Pubitemid 37385786)
5. Nir D, Kreitler S,. Pain and quality of life. Pain Pract 2001; 1: 150-161.
6. Moore ND,. In search of an ideal analgesic for common acute pain. Acute Pain 2009; 11: 129-137.
7. Woodcock J, et al,. Stimulating the development of mechanism-based, individualized pain therapies. Nat Rev Drug Discov 2007; 6: 703-710. (Pubitemid 47338179)
8. Lahlou M,. Essential oil and fragrances compounds: bioactivity and mechanisms of action. Flavor Frag J 2004; 19: 159-165. (Pubitemid 38401239)
9. Edris AE,. Pharmaceutical and therapeutic potential of essential oil and their individual volatile constituents: a review. Phytother Res 2007; 21: 308-323. (Pubitemid 46603595)
10. Bakkali F, et al,. Biological effects of essential oils-a review. Food Chem Toxicol 2008; 46: 446-475. (Pubitemid 350297552)
11. Bizzo RH, et al,. [Brazilian essential oil: general view, developments and perspectives]. Quim Nova 2009; 3: 588-594 [in Portuguese].
12. Cozier A, et al,. Plant Secondary Metabolites: Occurrence, Structure and Role in Human Diet. Oxford: Blackwell Publishing, 2006: 372.
13. Pascual ME, et al,. Lippia: traditional uses, chemistry and pharmacology, a review. J Ethnopharmacol 2001; 76: 201-214. (Pubitemid 32640159)
14. Singh G, et al,. Chemical and biocidal investigation on essential oil of some Indian Curcuma species. Prog Cryst Growth Ch 2002; 45: 75-81.
15. Barazani O, et al,. Chemotypic differentiation in indigenous population of Foeniculum vulgare var. vulgare in Israel. Biochem Syst Ecol 2002; 30: 721-731.
16. Stashenko E, et al,. Analysis of volatile secondary metabolites from Colombian Xylopia aromatica (Lamarck) by different extraction and headspace methods and gas chromatography. J Chromatogr 2004; 1025: 105-113. (Pubitemid 37548454)
17. Napoli EM, et al,. Screening of the essential oil composition of wild Sicilian rosemary. Biochem Syst Ecol 2010; 38: 659-670.
18. Gilles M, et al,. Chemical composition and antimicrobial properties of essential oil of three Australian Eucalyptus species. Food Chem 2010; 119: 731-737.
19. Geron CD, Arnts RR,. Seasonal monoterpene and sesquiterpene emissions from Pinus taeda and Pinus virginiana. Atmos Environ 2010; 44: 4240-4251.
20. González-Molina E, et al,. Natural bioactive compounds of Citrus limon for food and health. J Pharm Biomed Anal 2010; 51: 327-345.
21. Vitalini S,. Traditional uses of medicinal plants in Valvestino (Italy). J Ethnopharmacol 2009; 121: 106-116.
22. Vendruscolo A, et al,. Antiinflamatory and antinociceptive activities of Zingiber officinale Roscoe essential oil in experimental animal models. Indian J Pharmacol 2006; 38: 58-59. (Pubitemid 43288657)
23. Zimmermann M,. Ethical guidelines for investigations of experimental pain in conscious animals. Pain 1983; 16: 109-110. (Pubitemid 13058546)
24. Reilly TP, et al,. Comparison of the in vitro cytotoxicity of hydroxylamine metabolites of sulfamethoxazole and dapsone. Biochem Pharmacol 1998; 55: 803-810. (Pubitemid 28319643)
25. Collier HOJ, et al,. The abdominal constriction response and its suppression by analgesic drugs in the mouse. Br J Pharmacol 1968; 32: 295-310.
26. Hunskaar S, Hole K,. The formalin test in mice: dissociation between inflammatory and non-inflammatory pain. Pain 1987; 30: 103-114. (Pubitemid 17094194)
27. Tjølsen A, et al,. The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
28. Sakurada T, et al,. The capsaicin test in mice for evaluating tachykinin antagonists in the spinal cord. Neuropharmacology 1992; 31: 1279-1285. (Pubitemid 23002112)
29. Santos ARS, Calixto JB,. Further evidence for the involvement of tachykinin receptor subtypes in formalin and capsaicin models of pain in mice. Neuropeptides 1997; 31: 381-389. (Pubitemid 27394786)
30. Beirith A, et al,. Mechanisms underlying the nociception and paw oedema caused by injection of glutamate into the mouse paw. Brain Res 2002; 924: 219-228. (Pubitemid 34102309)
31. Lopes LS, et al,. Antinociceptive effect on mice of the hydroalcoholic fraction and (-) epicatechin obtained from Combretum leprosum Mart & Eich. Braz J Med Biol Res 2010; 43: 1184-1192.
32. Vivancos GG, et al,. An electronic pressure-meter nociception paw test for rats. Braz J Med Biol Res 2004; 37: 391-399. (Pubitemid 38444530)
33. Cunha JM, et al,. Cytokine mediated inflammatory hyperalgesia limited by interleukin-1 receptor antagonist. Br J Pharmacol 2000; 130: 1418-1424. (Pubitemid 30488609)
34. Duham NW, Miya TS,. A note on a simple apparatus for detecting neurological deficit in rats and mice. J Am Pharm Assoc 1957; 46: 208-210.
35. Lapa JA, et al,. Methods of pharmacological evaluation of medicinal plants. Braz Soc Med Plants 2003; 1: 64-66. [In Portuguese].
36. Merck KGaA. Show physical-chemical characteristics of alfa-phellandrene. 2010. Available at: http://www.merckchemicals.com/brazil/%CE%B1-felandrene/MDA- CHEM-814893/p-.rGb.s1LaPoAAAEWeOEfVhTl (Accessed May 2011).
37. Tjølsen A, Hole K,. Animal models of analgesia. Pharmacol Pain 1997; 25: 1-20.
38. Ribeiro RA, et al,. Involvement of resident macrophages and mast cells in the writhing nociceptive response induced by zymosan and acetic acid in mice. Eur J Pharmacol 2000; 387: 111-118. (Pubitemid 30035382)
39. Lucena GMRS, et al,. Antinociceptive and anti-inflammatory properties from the bulbs of Cipura paludosa Aubl. J Ethnopharmacol 2007; 112: 19-25. (Pubitemid 46722595)
40. Farouk L, et al,. Evaluation of the analgesic effect of alkaloid extract of Peganum harmala L.: possible mechanisms involved. J Ethnopharmacol 2008; 115: 449-454. (Pubitemid 350299085)
41. Le Bars D, et al,. Animal models of nociception. Pharmacol Rev 2001; 53: 597-652. (Pubitemid 33136239)
42. Capone F, Aloisi AM,. Refinement of pain evaluation techniques. The formalin test. Irt Super Sanita 2004; 40: 223-229. (Pubitemid 39564083)
43. Amaral JF, et al,. Antinociceptive effect of the monoterpene R-(-)- limonene in mice. Biol Pharm Bull 2007; 30: 1217-1220. (Pubitemid 47037641)
44. Gonçalves JCR, et al,. Antinociceptive activity of (-)- carvone: evidence of association with decreased peripheral nerve excitability. Biol Pharm Bull 2008; 31: 1017-1020. (Pubitemid 351731988)
45. França DS, et al,. B vitamins induce an antinociceptive effect in the acetic acid and formaldehyde models of nociception in mice. Eur J Pharmacol 2001; 421: 157-164. (Pubitemid 32539416)
46. Oliveira FS, et al,. Antinociceptive effect of hydroxydihydrocarvone. Biol Pharm Bull 2008; 31: 588-591.
47. Sakurada T, et al,. Mechanisms of nociception evoked by intrathecal high-dose morphine. Neurotoxicology 2005; 25: 801-809. (Pubitemid 41427520)
48. Millan MJ,. The induction of pain: an integrative review. Prog Neurobiol 1999; 57: 161-164.
49. Sakurada T, et al,. Differential effects of intraplantar capsazepine and ruthenium red on capsaicin-induced desensitization in mice. Pharmacol Biochem Behav 2003; 75: 115-121. (Pubitemid 36577586)
50. Verri WA Jr, et al,. Hypernociceptive role of cytokines and chemokines: targets for analgesic drug development? Pharmacol Ther 2006; 112: 116-138. (Pubitemid 44301486)
51. Cunha TM, et al,. A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. Proc Natl Acad Sci U S A 2005; 102: 1755-1760. (Pubitemid 40209240)
52. Brito GA, et al,. Peripheral antinociceptive effect of pertussis toxin: activation of the arginine/NO/cGMP/PKG/ATP-sensitive K channel pathway. Eur J Neurosci 2006; 24: 1175-1181. (Pubitemid 44268147)
53. Jones PG, Dunlop J,. Targeting the cholinergic system as a therapeutic strategy for the treatment of pain. Neuropharmacology 2007; 53: 197-206. (Pubitemid 47187447)
54. Rathmell JP, et al,. The role of intrathecal drugs in the treatment of acute pain. Anesth Analg 2005; 101: 30-43.